Thomas P. O'Neil's Net Worth
$1.63 Million
Who is Thomas P. O'Neil?
Thomas P. O'Neil has an estimated net worth of $1.63 Million. This is based on reported shares across multiple companies, which include Protagonist Therapeutics, Inc, Arcadia Biosciences, Inc., and Satsuma Pharmaceuticals, Inc..
SEC CIK
Thomas P. O'Neil's CIK is 0001640645
Past Insider Trading and Trends
2020 was Thomas P. O'Neil's most active year for acquiring shares with 11 total transactions. Thomas P. O'Neil's most active month to acquire stocks was the month of May. 2020 was Thomas P. O'Neil's most active year for disposing of shares, totalling 16 transactions. Thomas P. O'Neil's most active month to dispose stocks was the month of May. 2017 saw Thomas P. O'Neil paying a total of $21,480.00 for 8,000 shares, this is the most they've acquired in one year. In 2017 Thomas P. O'Neil cashed out on 16,000 shares for a total of $160,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $41.5
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +223.04% | 21.1K |
—
|
—
| 30.56K |
Aug 15
| |||
Form 4
| +209.94% | 6K |
—
|
—
| 8.86K |
Feb 28
| |||
Form 4
|
—
|
0
|
$11.35 | -$138,520.00 | 8K |
Scheduled
|
Dec 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcadia Biosciences, Inc. (RKDA) Snapshot price: $2.85
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Satsuma Pharmaceuticals, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.88K |
$0.91 | -$12,628.07 |
0
|
Jun 6 - Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
$13.38 | -$13,224.52 |
0
|
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$14.78 | -$20,440.00 |
0
|
Scheduled
|
Aug 5
| ||
Form 4
|
—
|
0
|
$15.60 | -$22,093.92 |
0
|
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$18.13 | -$72,312.27 |
0
|
Scheduled
|
Jun 23
| ||
Form 4
|
—
|
0
|
$14.94 | -$20,763.50 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$14.78 | -$40,880.00 |
0
|
Scheduled
|
May 20
| ||
Form 4
|
—
|
0
|
$16.12 | -$23,118.00 |
0
|
Scheduled
|
Mar 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||